Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
4.300
+0.260 (6.44%)
Jul 27, 2026, 12:23 PM EDT - Market open
Outset Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 30.56 | 35.01 | 124.01 | 68.51 | 73.22 | 182.35 |
Short-Term Investments | 126.14 | 133.94 | 34.67 | 134.82 | 214.28 | 157.14 |
Cash & Short-Term Investments | 156.71 | 168.95 | 158.69 | 203.32 | 287.5 | 339.49 |
Cash Growth | -17.09% | 6.47% | -21.95% | -29.28% | -15.31% | 7.82% |
Accounts Receivable | 25.32 | 28.33 | 35.62 | 32.98 | 28.07 | 25.6 |
Inventory | 49.65 | 47.61 | 59.39 | 49.22 | 51.48 | 39.19 |
Other Current Assets | 5.03 | 6 | 4.53 | 5.7 | 6.6 | 5.53 |
Total Current Assets | 236.71 | 250.88 | 258.22 | 291.22 | 373.65 | 409.8 |
Net Property, Plant & Equipment | 8.56 | 9.47 | 12.07 | 18.65 | 21.99 | 20.2 |
Other Long-Term Assets | 3.83 | 3.83 | 3.33 | 3.93 | 4.48 | 33.47 |
Total Assets | 249.45 | 264.5 | 275.8 | 313.8 | 400.12 | 463.46 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | - | - | 5.83 | 0.6 | 1.76 |
Accrued Expenses | 8.75 | 10.74 | 16.82 | 36.18 | 41.37 | 42.44 |
Current Portion of Leases | 1.82 | 1.74 | 1.8 | 1.59 | 1.32 | 1.15 |
Unearned Revenue | - | - | - | 11.73 | 8.66 | 6.34 |
Total Current Liabilities | 37.61 | 37.63 | 45.38 | 55.32 | 51.95 | 51.7 |
Long-Term Debt | - | - | - | 130.11 | 96.34 | 29.76 |
Long-Term Leases | 2.86 | 3.27 | 2.68 | 4.48 | 5.58 | 6.89 |
Other Long-Term Liabilities | - | - | 2.7 | 1 | 0.26 | 1.03 |
Total Long-Term Liabilities | 2.86 | 3.27 | 5.38 | 135.59 | 102.18 | 37.69 |
Total Liabilities | 40.46 | 40.9 | 50.76 | 190.92 | 154.13 | 89.38 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | - | - | 0.05 | 0.05 | 0.05 |
Additional Paid-in Capital | - | - | - | 1,085 | 1,035 | 1,000 |
Accumulated Other Comprehensive Income | -0.07 | 0.17 | 0.04 | 0.07 | -0.56 | -0.18 |
Retained Earnings | -1,190 | -1,171 | -1,090 | -961.75 | -788.95 | -625.99 |
Shareholders' Equity | -1,190 | -1,171 | -1,090 | 122.89 | 245.99 | 374.08 |
Total Liabilities & Equity | 249.45 | 264.5 | 275.8 | 313.8 | 400.12 | 463.46 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4.68 | 5.01 | 4.48 | 136.19 | 103.23 | 37.81 |
Net Cash (Debt) | 152.03 | 163.94 | 154.2 | 67.14 | 184.27 | 301.68 |
Net Cash Growth | 67.37% | 6.31% | 129.69% | -63.57% | -38.92% | 9.20% |
Net Cash Per Share | 8.48 | 10.78 | 44.53 | 20.31 | 57.39 | 99.26 |
Book Value | -1,190 | -1,171 | -1,090 | 122.89 | 245.99 | 374.08 |
Book Value Per Share | -66.40 | -77.00 | -314.66 | 37.18 | 76.61 | 123.08 |
Tangible Book Value | -1,190 | -1,171 | -1,090 | 122.89 | 245.99 | 374.08 |
Tangible Book Value Per Share | -66.40 | -77.00 | -314.66 | 37.18 | 76.61 | 123.08 |